XAMS
IMCD
Market cap6.47bUSD
Sep 17, Last price
95.46EUR
1D
-0.38%
1Q
15.63%
Jan 2017
135.76%
IPO
320.53%
Name
IMCD NV
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in Rotterdam, the Netherlands, in 1995, IMCD N.V. operates as a leading global distributor and marketer of a diverse range of specialized chemicals and premium ingredients. Its extensive operations span across the Netherlands, the wider European continent, the Middle East, Africa, both North and South America, and the Asia-Pacific region. IMCD's comprehensive product portfolio serves numerous industries. For the pharmaceutical, agrochemical, and nutraceutical sectors, it provides essential active ingredients, excipients, formulation components, and compounds for regulated synthesis. Within personal care and cosmetics, the company supplies a wide array of offerings including active substances, UV filters, rheology modifiers, thickeners, emulsifiers, emollients, colorants, fragrances, and various functional additives for skin and hair products. Industrial applications benefit from resins, binders, functional fillers, and specialized solvents. Additionally, IMCD offers solutions for the food and beverage industry, focusing on enhancing taste, improving texture, and boosting nutritional value. The company also supports the energy sector with base oils, fuel and lubricant additives, and related fluids, alongside a broad spectrum of bio-based chemicals, catalysts, intermediates, and organic building blocks for various chemical processes.
Related entities
Subsidiaries (9)
IMCD Benelux B.V.
IMCD Deutschland GmbH
IMCD Finance B.V.
IMCD FRANCE SAS
IMCD Group B.V.
IMCD POLSKA SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
IMCD UK LIMITED
IMCD BENELUX
IMCD PORTUGAL - PRODUTOS QUÍMICOS, LDA
Key people
Michel G. P. Plantevin
Independent Chairman of the Supervisory Board · since 2011
Headquarters & legal address
Wilhelminaplein 32
Rotterdam 3072DE
NL
Rotterdam 3072DE
NL
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||